US 11352607
Genomic engineering of pluripotent cells
granted A61KA61K2035/124A61K2239/31
Quick answer
US patent 11352607 (Genomic engineering of pluripotent cells) held by Fate Therapeutics, Inc. expires Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Fate Therapeutics, Inc.
- Grant date
- Tue Jun 07 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 02 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2035/124, A61K2239/31, A61K2239/38, A61K40/10